BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16996550)

  • 1. Experimental and mathematical modeling methods for the investigation of toxicological interactions.
    El-Masri HA
    Toxicol Appl Pharmacol; 2007 Sep; 223(2):148-54. PubMed ID: 16996550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational estimation of errors generated by lumping of physiologically-based pharmacokinetic (PBPK) interaction models of inhaled complex chemical mixtures.
    LeFew W; El-Masri H
    Inhal Toxicol; 2012 Jan; 24(1):36-46. PubMed ID: 22149415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated approaches for the analysis of toxicologic interactions of chemical mixtures.
    el-Masri HA; Reardon KF; Yang RS
    Crit Rev Toxicol; 1997 Mar; 27(2):175-97. PubMed ID: 9099518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PBPK models in risk assessment--A focus on chloroprene.
    DeWoskin RS
    Chem Biol Interact; 2007 Mar; 166(1-3):352-9. PubMed ID: 17324392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the relevance of rodent data on chemical interactions for health risk assessment purposes: a case study with dichloromethane-toluene mixture.
    Pelekis M; Krishnan K
    Regul Toxicol Pharmacol; 1997 Feb; 25(1):79-86. PubMed ID: 9056503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods for deriving pesticide aquatic life criteria.
    TenBrook PL; Tjeerdema RS; Hann P; Karkoski J
    Rev Environ Contam Toxicol; 2009; 199():19-109. PubMed ID: 19110939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substance-tailored testing strategies in toxicology: an in silico methodology based on QSAR modeling of toxicological thresholds and Monte Carlo simulations of toxicological testing.
    Péry AR; Desmots S; Mombelli E
    Regul Toxicol Pharmacol; 2010 Feb; 56(1):82-92. PubMed ID: 19766156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial analyses of the relationship between "Thresholds" of toxicity for individual chemicals and "Interaction Thresholds" for chemical mixtures.
    Yang RS; Dennison JE
    Toxicol Appl Pharmacol; 2007 Sep; 223(2):133-8. PubMed ID: 17292430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A weight-of-evidence approach for assessing interactions in chemical mixtures.
    Mumtaz MM; Durkin PR
    Toxicol Ind Health; 1992; 8(6):377-406. PubMed ID: 7570620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporating physiological and biochemical mechanisms into pharmacokinetic-pharmacodynamic models: a conceptual framework.
    Dahl SG; Aarons L; Gundert-Remy U; Karlsson MO; Schneider YJ; Steimer JL; Trocóniz IF
    Basic Clin Pharmacol Toxicol; 2010 Jan; 106(1):2-12. PubMed ID: 19686541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A unifying concept for assessing toxicological interactions: changes in slope.
    Gennings C; Carter WH; Carchman RA; Teuschler LK; Simmons JE; Carney EW
    Toxicol Sci; 2005 Dec; 88(2):287-97. PubMed ID: 16081521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of the toxicity of chemical mixtures: Theory, policy, and regulatory practice.
    McCarty LS; Borgert CJ
    Regul Toxicol Pharmacol; 2006 Jul; 45(2):119-43. PubMed ID: 16701933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose addition and the isobole method as approaches for predicting the cumulative effect of non-interacting chemicals: a critical evaluation.
    Bosgra S; van Eijkeren JC; Slob W
    Crit Rev Toxicol; 2009; 39(5):418-26. PubMed ID: 19514914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can mode of action predict mixture toxicity for risk assessment?
    Borgert CJ; Quill TF; McCarty LS; Mason AM
    Toxicol Appl Pharmacol; 2004 Dec; 201(2):85-96. PubMed ID: 15541748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicity assessment of unintentional exposure to multiple chemicals.
    Mumtaz MM; Ruiz P; De Rosa CT
    Toxicol Appl Pharmacol; 2007 Sep; 223(2):104-13. PubMed ID: 17599373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of physiologically based pharmacokinetic models for use in risk assessment.
    Chiu WA; Barton HA; DeWoskin RS; Schlosser P; Thompson CM; Sonawane B; Lipscomb JC; Krishnan K
    J Appl Toxicol; 2007; 27(3):218-37. PubMed ID: 17299829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of physiologically-based pharmacokinetic modeling to investigate the toxicological interaction between chlorpyrifos and parathion in the rat.
    El-Masri HA; Mumtaz MM; Yushak ML
    Environ Toxicol Pharmacol; 2004 Mar; 16(1-2):57-71. PubMed ID: 21782694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicology of chemical mixtures: a challenging quest along empirical sciences.
    Groten JP; Heijne WH; Stierum RH; Freidig AP; Feron VJ
    Environ Toxicol Pharmacol; 2004 Dec; 18(3):185-92. PubMed ID: 21782748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiologically based pharmacokinetics (PBPK).
    Espié P; Tytgat D; Sargentini-Maier ML; Poggesi I; Watelet JB
    Drug Metab Rev; 2009; 41(3):391-407. PubMed ID: 19601719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.